GLP-1 Drugs Linked to Lower Death Risk After Diabetic Foot Ulcers | Research

The takeaway

Nationwide French study finds GLP-1 receptor agonist use is associated with significantly reduced 1-year mortality following first diabetic foot ulcer.

Reduced 1-year mortality
GLP-1 RA users had significantly lower death rates after first diabetic foot ulcer

What the researchers found

GLP-1 RA use was associated with reduced 1-year mortality following first diabetic foot ulcer in a nationwide French cohort, with secondary analysis also examining mortality after major lower-limb amputation.

Why it matters

Diabetic foot ulcer patients have a 5-year mortality rate approaching 50%. Any treatment that reduces mortality in this population could save thousands of lives annually.

How the study worked

Retrospective nationwide cohort study using the French SNDS health data system, identifying adults with incident diabetic foot ulcers and analyzing associated factors for 1-year mortality.

What this study cannot tell us

Observational design — cannot prove GLP-1 drugs caused the survival benefit. Healthy user bias possible. French healthcare system may not generalize globally.

How to read the evidence

Large nationwide observational cohort — strong real-world evidence but cannot establish causation.

When this study was published

Published in 2026; uses comprehensive French national health data.

The bigger picture

This adds to mounting evidence that GLP-1 drugs reduce mortality across multiple diabetic complications, strengthening the case for earlier and broader use.

Questions still open

Should GLP-1 drugs be prioritized for diabetes patients with foot ulcer risk?
What mechanism explains the mortality reduction — improved wound healing, cardiovascular protection, or both?

Common questions

Can GLP-1 drugs help diabetic foot ulcers?

This large national study found that patients on GLP-1 drugs had significantly lower death rates after diabetic foot ulcers. While the drugs may not directly heal ulcers, they appear to improve overall survival in this high-risk group.

Why are diabetic foot ulcers so dangerous?

Diabetic foot ulcers can lead to serious infections, amputation, and death. Patients with foot ulcers have a 5-year mortality rate approaching 50%, making them one of the highest-risk diabetes populations.

Read the original research

GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study.

Diabetes care

View on PubMed ↗Publisher’s paper ↗

Citation

Bonnet, Jean-Baptiste; Huguet, Helena; Avignon, Antoine; Duflos, Claire; Sultan, Ariane. (2026). GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study.. Diabetes care. https://doi.org/10.2337/dc25-2120